Skip to main content

Collaborative Care Approaches for Mgmt. of OUD - 8 CME Credits

Collaborative strategies for ongoing management of opioid use disorder

Start Date: June 1, 2017
Duration: ~8 hours
Price: Free

Course Description

This course is one of three that comprise the Opioid Use Disorder Education Program (OUDEP), an innovative continuing medical education program produced by Harvard Medical School (HMS). Thank you to the National Institute on Drug Abuse, part of the National Institutes of Health, for providing scientific contributions to this course. This course is intended for nurses, nurse practitioners, physician assistants, physicians, social workers, and other health care providers collaborating to treat patients with substance use disorders.

Collaborative Care Approaches for the Management of OUD focuses on collaborative care strategies which include: provider roles and regulatory requirements; patient evaluation and patient education; transitioning between medications; potential misuse, relapse, and safer use; and caring for pregnant women and other special populations with OUD.

What You'll Learn

  • Identify provider’s role and legal regulations in a collaborative care model of treating opioid use disorder
  • Explain methods for assessing, screening, and educating patients for treatment of opioid use disorder
  • Recognize steps required to initiate, stabilize, transition, and maintain treatment with medications including buprenorphine, buprenorphine-naloxone, and naltrexone
  • Communicate effectively with patients who may be misusing opioids about potential interventions, methods of mitigation, and strategies of care
  • Describe special populations affected by opioid use disorder, including pregnant women, families and children, pain-management patients, and patients with co-occurring medical issues

Instructors

Lena Asmar, MSW, LICSW

Lena Asmar, MSW, LICSW Director, Veteran 360 Behavioral Health Programs at the New England Center and Home for Veterans; Section Instructor, Simmons College Graduate School of Social Work

Roger Chou, MD

Roger Chou, MD Professor in the Departments of Medicine, and Medical Informatics & Clinical Epidemiology, Staff Physician, Oregon Health & Science University (OHSU) School of Medicine; Director of the Pacific Northwest Evidence-Based Practice Center

Colleen LaBelle, MSN, RN-BC, CARN

Colleen LaBelle, MSN, RN-BC, CARN Program Director, MA Technical Assistance Treatment Expansion of Buprenorphine (STATE OBOT-B) Program

Stephen Martin, MD, EdM

Stephen Martin, MD, EdM Affiliate Faculty, Center for Primary Care, Harvard Medical School; Associate Professor, Family Medicine and Community Health, University of Massachusetts Medical School; Physician and Residency Faculty, Barre Family Health Center

Leena Mittal, MD

Leena Mittal, MD Instructor of Psychiatry, Harvard Medical School; Director, Reproductive Psychiatry Consultation Service, Divisions of Women’s Mental Health and Medical Psychiatry, Department of Psychiatry, Brigham and Women’s Hospital; Associate Medical Director, MCPAP for Moms

Kristin Wason, MSN, APRN, CARN

Kristin Wason, MSN, APRN, CARN Registered Nurse (CARN), Boston Medical Center Office-Based Addiction Treatment Program

COURSE OUTLINE

Collaborative Care Approaches for Management of Opioid Use Disorder covers the following eight units:

  • 1. Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Disorder
  • 2. Patient Assessment, Screening, and Education for Initiation of Buprenorphine/Naloxone
  • 3. Initiation of Medication in Treating Opioid Use Disorder
  • 4. Stabilization, Maintenance, and Expected Struggles in Treating Opioid Use Disorder
  • 5. Managing Pain in Patients on Pharmacotherapy for Opioid Use Disorder
  • 6. Treatment of Opioid Use Disorder in the Perinatal Patient
  • 7. Effective Communication with Patients Who May Be Misusing Opioids or Other Medication
  • 8. Special Populations with Opioid Use Disorder and Related Issues

    Learners must pass a final posttest with a score of 80% or higher to claim their CME certificate. (This grade corresponds to social worker CME regulation and also covers each of the other specialties.)

  • ACCREDITATION AND AMA CREDIT DESIGNATION STATEMENTS

    Accreditation Statement

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Harvard Medical School and the National Institute on Drug Abuse. The Harvard Medical School is accredited by the ACCME to provide continuing medical education for physicians.

    AMA Credit Designation Statement

     ACCME logo

    The Harvard Medical School designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Risk Management

    This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 8 credits of Risk Management Study. This includes 8 Credits of Opioid Education and Pain Management Training. Please check your individual state licensing board requirements before claiming these credits.

    Nurses

    This continuing nursing education activity was approved by the American Nurses Association Massachusetts (ANA MASS), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This activity was approved for 8.0 contact hours.

    Nurse Practitioners

     AANP logo

    This activity is approved 8.0 contact hour(s) of continuing education (which includes 8.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 17052674. This activity was planned in accordance with AANP CE Standards and Policies.

    Physician Assistants

    AAPA logo

    This program has been reviewed and is approved for a maximum of 8.0 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of 06/1/2017. Participants may submit the post-test at any time during that period.

    This program was planned in accordance with the AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

    Social Workers

    NASW logo

    This program is Approved by the National Association of Social Workers (Approval #886752424-3783) for 8 continuing education contact hours.

    DISCLOSURE STATEMENT

    Disclosure Policy

    Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

    In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

    Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

    Disclosure Statement

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Harvard Medical School and the National Institute on Drug Abuse. The Harvard Medical School is accredited by the ACCME to provide continuing medical education for physicians.

    The Harvard Medical School designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 8 credits of Risk Management Study. This includes:

    8 Credits of Opioid Education and Pain Management Training

    Please check your individual state licensing board requirements before claiming these credits.

    Unlabeled/Investigation Uses of Products or Devices:

    Dr. Leena Mittal will discuss off-label treatment as there are no approved treatments for OUD in pregnancy.

    The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

    Name: Patricia Bruckenthal, PhD, APRN-BC, ANP
    Role: Course Planner
    Company: Endo Pharmaceuticals
    Relationship: Speaker’s Bureau

    Name: John A. Renner, Jr., MD
    Role: Course Planner
    Companies: Johnson and Johnson, General Electric
    Relationship: Stockholder

    Name: Richard Saitz, MD, MPH, FACP, DFASAM
    Role: Course Planner
    Company: Alkermes
    Relationship: Provide Medication for NIH-Funded Trial

    Name: Ajay K. Singh, MBBS, FRCP (UK), MBA
    Role: Course Planner
    Company: GlaxoSmithKline
    Relationship: Research Support
    Company: Novartis
    Relationship: Honoraria

    Name: Leena Mittal, MD
    Role: Course Faculty
    Company: Sage Therapeutics
    Relationship: Uncompensated Investigator on a Clinical Trial
    Company: GLG Consulting
    Relationship: Consultant
    Company: Pennside Partners
    Relationship: Consultant

    Name: Lowell Schnipper, MD
    Role: HMS Committee on Proposal Review Member
    Company: NantHealth, Inc
    Relationship: Advisory Board Member

    Name: Lindsay Baden, MD
    Role: HMS Committee on Proposal Review Member
    Companies: HIV Vaccine Trials Network, International AIDS Vaccine Initiative, Crucell/Janssen, Military HIV Research Program
    Relationship: Clinical Trials

    All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.

    COURSE DIRECTOR

    Colleen LaBelle, MSN, RN-BC, CARN, is board certified in addiction nursing and pain management with over 30 years of clinical experience in HIV and addiction. She pioneered the start-up of Boston Medical Center's Office-Based Treatment Addiction Treatment program, the largest such hospital-based program. She is the program director of the State Technical Assistance Treatment Expansion of Buprenorphine (STATE OBOT-B), disseminating the nurse care manager model to greater than 40 funded community health centers for the expansion of treatment for opioid use disorder. This model has recently been recognized as an evidence-based practice model by the Agency for Healthcare Research and Quality (AHRQ), and dubbed the MA Model by SAMHSA. The Massachusetts Department of Public Health (MDPH), Bureau of Substance Abuse Services, supports this initiative, which has allowed for widespread dissemination of treatment in community settings, engaging providers and treating more than 11,000 patients since its inception.

    She serves as faculty for the buprenorphine certification course under DATA 2000 (Drug Addiction Treatment Act), and as clinical expert for AMERSA along with Provider Clinical Support Services (PCSS), a partner with SAMHSA to educate, train, and support clinical providers in addiction work. She is a member of the Governor's Task Force for Opioids, and is a board member of the Massachusetts Board of Registration in Nursing. She is co-author on the BMC model, and recently authored "Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of Massachusetts Collaborative Care Model in community health centers." She was the recipient of Individual Leadership Award for Innovation in Health Care, NIATX award recipient 2011 Innovations in Behavioral Health Services iAward, Science and Service Award from SAMHSA, Mayoral Prize for Innovations in Primary Care in Addiction Treatment, and recently, Excellence in Nursing from Modern Healthcare, recipient of the Gage award from America's Essential Hospitals for population health. She serves as board member and treasurer of the International Society of Nurses Addiction Certification Board, and is executive director for the Massachusetts Chapter of the International Nurses Society on Addictions that she started in 2006, the largest statewide chapter in addiction nursing.

    STEERING COMMITTEE

    Dan Alford, MD, MPH, is professor of medicine, assistant dean of Continuing Medical Education, and director of the Safe and Competent Opioid Prescribing Education Program at Boston University School of Medicine. He is on staff in the Section of General Internal Medicine, director of the Clinical Addiction Research and Education (CARE) Unit, and medical director of the Office-Based Addiction Treatment program at Boston Medical Center. He is immediate past-president of the National Association for Medical Education and Research in Substance Abuse. In 2011, he was recognized as a Champion of Change by the White House. In 2014, he received the AMA Award for Health Education and in 2016, was awarded the American Society of Addiction Medicine Educator of the Year Award and the American College of Physicians Award for Distinguished Contributions to Behavioral Medicine. His clinical, educational, and research interests focus on opioid use disorders and safe and competent opioid prescribing for chronic pain.

    Quandra Blackeney, MS, is a scientific program analyst in the Center for the Clinical Trials Network (CCTN) at the National Institute on Drug Abuse (NIDA)/NIH. She joined the CCTN in January 2006. She coordinates information on scientific programs within the office, which includes program announcements, grant applications using the CCTN as a platform, working with CCTN investigators, and other investigators. She provides administrative, technical, and managerial support for the CCTN, working closely with staff and other branches within the institute.

    Blackeney serves as project officer for the NIDA Blending Initiative: Moving Science from Research to Practice contract, CCTN’s Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) contracts and grants, and other contracts within the office. She serves on several internal and external committees and workgroups at the NIH and NIDA.

    Before joining NIDA, she was a program analyst at the National Institute of Neurological Disorders and Stroke (NINDS) for six years (1999), where she worked with program staff in Neurogenetics on grants, contracts, and other extramural program activities. She was also a program analyst in the Epidemiology and Biometry Program (EBP) at the National Heart, Lung, and Blood Institute (NHLBI), where she began her NIH career in 1995. Mrs. Blackeney has over 15 years of experience in grants and contracts, and clinical trials at the National Institutes of Health (NIH).

    Deborah Finnell, DNS, PMHNP-BC, CARN-AP, FAAN, has specialized in mental health and addictions for the majority of her career. From her grounding as a registered nurse working in inpatient psychiatry, she expanded her role to that of a clinical nurse specialist and then a nurse practitioner. She brings her passion for the neurobiological bases of mental health and addictions to her clinical practice, teaching, research, and policy/advocacy. With funding from the Substance Abuse and Mental Health Services Administration (SAMHSA), Dr. Finnell led the integration of substance-use related content including screening, brief intervention, and referral to treatment (SBIRT) into the nursing curricula at Johns Hopkins School of Nursing. She advocates for expanded access to mental health and substance use treatment, including calling for advanced practice nurses to prescribe buprenorphine. Over her decade with the Department of Veterans Affairs, Veterans Hospital Administration, she conducted funded research focusing on improving the health of veterans with mental and substance use disorders.

    Her professional leadership roles range from past chair of the New York State Peer Assistance Committee to past president of the International Nurses Society on Addictions. She served as chair of the Addictions Nursing Certification Board and also was a member of the Committee on Nursing Standards for the American Nurses Association. She currently serves on the board of the Association for Medical Education and Research in Substance Abuse (AMERSA) and is associate editor of that organization’s professional journal, Substance Abuse.

    Kristen Huntley, PhD, is a health scientist administrator at the National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), Center for Clinical Trials Network (CCTN) where she oversees research studying the effectiveness and implementation of interventions for the treatment of substance use disorders in multi-site, nationwide studies that enroll large samples of diverse participants in general medical settings and community-based treatment programs. Dr. Huntley also manages activities conducted through NIDA’s Blending Initiative. This initiative supports collaboration between clinicians, scientists, and experienced educators to facilitate the adoption of evidence-based practices in front-line clinical settings.

    During her tenure at NIH, Dr. Huntley has served as a scientific review officer at NIDA and as a program director at the National Center for Complementary and Integrative Health (NCCIH), where she administered a portfolio of pain management research grants and led efforts to build collaborations with other federal agencies to encourage research on the use of integrative models of care in military and veteran populations. Prior to working at NIH, Dr. Huntley was on the faculty at Case Western Reserve University School of Medicine, a project director at a research and consulting firm, and has worked in a variety of health care settings. Dr. Huntley has a PhD in clinical psychology and has over 20 years of experience in academic, research, and clinical settings.

    Petra Jacobs, MD, MHS, is an addiction psychiatrist with expertise in prevention and treatment of mental health and substance use disorder including HIV/AIDS comorbidities, with 20 years developing treatment, research, education, and training initiatives. She designed and led multiple large-scale programs focused on treatment of substance use disorder, including alcohol use disorder in the US, Europe, and Latin America. Currently, she works as the Addiction Medicine Team leader and HIV/AIDS program director in the Center for the Clinical Trials Network at NIDA.

    Catherine Judd, MS, PA-C, CAQ Psychiatry, DFAAPA, is a senior PA at Parkland Health and Hospital System, Jail Mental Health Program, Dallas Texas and clinical instructor and psychiatry preceptor at the University of Texas, Dallas, PA Program. She was among the first to earn the NCCPA CAQ in psychiatry. She is a national speaker for the CO-REMS, Collaborative Risk Management Reduction Initiative on prescribing opiates, and on the curriculum advisory committee. She has served as a representative from AAPA on the Accreditation Review Commission for PA Education Programs, and on the National Commission on Certification of Physician Assistants (NCCPA) Certificate of Advanced Qualification in Psychiatry Committee.

    Her clinical practice over the past 30 years has been primarily focused on mental health, including substance use disorders. She has worked internationally in Egypt in addition to a private aid organization in Ghana. She has a special interest in patients with serious mental illness and comorbid substance use disorders as well as in the educational needs of health care providers regarding comorbid substance use disorders and psychiatric illness. She was recently named the 2015 Educator of the Year at the School of Allied Health Professions, University of Texas Southwestern Medical Center.

    Colleen LaBelle, MSN, RN-BC, CARN, is board certified in addiction nursing and pain management with over 30 years of clinical experience in HIV and addiction. She pioneered the start-up of Boston Medical Center's Office-Based Treatment Addiction Treatment program, the largest such hospital-based program. She is the program director of the State Technical Assistance Treatment Expansion of Buprenorphine (STATE OBOT-B), disseminating the nurse care manager model to greater than 40 funded community health centers for the expansion of treatment for opioid use disorder. This model has recently been recognized as an evidence-based practice model by the Agency for Healthcare Research and Quality (AHRQ), and dubbed the MA Model by SAMHSA. The Massachusetts Department of Public Health (MDPH), Bureau of Substance Abuse Services, supports this initiative, which has allowed for widespread dissemination of treatment in community settings, engaging providers and treating more than 11,000 patients since its inception.

    She serves as faculty for the buprenorphine certification course under DATA 2000 (Drug Addiction Treatment Act), and as clinical expert for AMERSA along with Provider Clinical Support Services (PCSS), a partner with SAMHSA to educate, train, and support clinical providers in addiction work. She is a member of the Governor's Task Force for Opioids, and is a board member of the Massachusetts Board of Registration in Nursing. She is co-author on the BMC model, and recently authored "Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of Massachusetts Collaborative Care Model in community health centers." She was the recipient of Individual Leadership Award for Innovation in Health Care, NIATX award recipient 2011 Innovations in Behavioral Health Services iAward, Science and Service Award from SAMHSA, Mayoral Prize for Innovations in Primary Care in Addiction Treatment, and recently, Excellence in Nursing from Modern Healthcare, recipient of the Gage award from America's Essential Hospitals for population health. She serves as board member and treasurer of the International Society of Nurses Addiction Certification Board, and is executive director for the Massachusetts Chapter of the International Nurses Society on Addictions that she started in 2006, the largest statewide chapter in addiction nursing.

    David Liu, MD, is a medical officer and team leader in the Center for the Clinical Trials Network at the National Institute on Drug Abuse. He is a member of the American Board of Addiction Medicine’s Lifelong Learning and Self-Assessment Committee. Dr. Liu is a graduate of Harvard College and the University of Maryland School of Medicine.

    Ajay Singh, MBBS, FRCP, MBA, is senior associate dean for Global and Continuing Education at Harvard Medical School and director of the Master in Medical Sciences in Clinical Investigation (MMSCI) program. He leads a vibrant group of faculty and staff in developing and overseeing postgraduate medical education at HMS, as well as the Master's program in Clinical Investigation. He has been executive director for the Dubai Harvard Foundation of Medical Research since 2008.

    Dr. Singh completed his undergraduate and medical training in England at University College London School of Medicine. He moved to Boston in 1987 for his clinical and research renal fellowship at Tufts-New England Medical Center, which he finished in 1992 when he joined the Tufts University faculty. In 1998, he moved to the Brigham and Women’s Hospital—one of the principal teaching hospitals of Harvard Medical School—as clinical director of the Renal Division and director, Dialysis Services, and associate professor of medicine at HMS. In 2008, he became chief academic officer and executive director, Dubai Harvard Foundation for Medical Research (DHFMR).

    Dr. Singh’s interests are in clinical research with a particular focus on the anemia of chronic kidney disease. He led groundbreaking studies in anemia of kidney disease, including the CHOIR study, which was published in The New England Journal of Medicine, and well as being a member of the steering committees for the TREAT and DRIVE studies. More recently, he has taken on the role of leading the ASCEND Clinical Development Program—a phase III program for the development of a novel propel hydroxyls inhibitor, daprodustat. The trial is aiming to recruit 7,500 patients in over countries.

    Dr. Singh is currently editor-in-chief of Scientific American Medicine and also chair of the Editorial Board for Nephrology Times. He leads the office of Postgraduate Medical Education at the Brigham and Women's Hospital and in this capacity leads several HMS CME courses. He is the author of over 150 original contributions and review articles, as well as author/editor of 11 books in internal medicine and nephrology. Dr. Singh is a fellow of the Royal College of Physicians in London, and has an MBA from Boston University.

    Joji Suzuki, MD, is the director of the Division of Addiction Psychiatry and director of Addictions Education in the Department of Psychiatry at Brigham and Women’s Hospital, and an assistant professor of psychiatry at Harvard Medical School. He completed his undergraduate and medical school at Boston University, general psychiatry residency at Maine Medical Center, and an addiction psychiatry fellowship at Boston University School of Medicine.

    Dr. Suzuki is a consultation-liaison psychiatrist in the Division of Medical Psychiatry at Brigham and Women’s Hospital, working with both inpatients and outpatients focusing on providing evidenced-based addiction treatment in general medical settings. Dr. Suzuki serves as the site director for the Addiction Psychiatry Fellowships for both Partners and Boston University School of Medicine, and is very active in medical student and resident education. He is the director of the Addiction and Their Treatment course for the American Academy of Addiction Psychiatry, directs a Harvard Medical School CME course on motivational interviewing, and is a member of the Motivational Interviewing Network of Trainers.

    Dr. Suzuki conducts clinical and educational research focused on studying novel approaches to addiction treatment as well as integrating addiction treatment into general medical settings. His research is focused on applying consultation-liaison approaches to addiction psychiatry, such as implementation of collaborative models of care of addiction treatment in the general hospital, primary care, and specialty care settings. His research has received funding from NIH, Brigham and Women’s Hospital, and Harvard Medical School. He currently serves on a variety of committees, workgroups, and taskforces for Partners HealthCare, Brigham and Women’s Hospital, Massachusetts Hospital Association, and the state of Massachusetts to address the opioid epidemic. He has published over 40 peer-reviewed manuscripts and book chapters.

    Kevin Tucker, MD, is an associate physician at Brigham and Women’s Hospital and assistant professor of medicine at Harvard Medical School. He is also the chief of nephrology at Brigham and Women’s/Faulkner Hospital and director of the Joint Nephrology Fellowship Program of Brigham and Women’s Hospital and Massachusetts General Hospital.

    Dr. Tucker received his undergraduate education at Birmingham-Southern College and completed his medical education at Cornell University Medical College. He trained in internal medicine at Massachusetts General Hospital and in nephrology at the University of Alabama at Birmingham.

    Sarah Wakeman, MD, is medical director of the Substance Use Disorder Initiative and the Addiction Consult Team at Massachusetts General Hospital (MGH), co-chair of the Mass General Opioid Task Force, and clinical lead for the Partners Healthcare Substance Use Disorder Initiative. Dr. Wakeman is also an assistant professor in medicine at Harvard Medical School.

    Dr. Wakeman received her AB from Brown University and her MD from Brown Medical School. She completed residency training in internal medicine and served as chief medical resident at Mass General Hospital. She is a diplomate and a fellow of the American Board of Addiction Medicine.

    Dr. Wakeman’s clinical interest and expertise is in the care of patients with addiction within general medical settings. Clinically, she provides primary care and office-based addiction care, as well as inpatient specialty consultation for addiction. She teaches locally, regionally, and nationally about addiction and has led workshops and delivered invited symposia at national conferences. She was appointed by Gov. Charlie Baker to serve on his Opioid Addiction working group. She serves as secretary for the Massachusetts Society of Addiction Medicine (MASAM) and chair of the MASAM policy committee.

    In addition to providing clinical care and teaching, she conducts research on physician preparedness and attitudes related to addiction. She has studied the quality of training resident physicians receive in addiction medicine. She has ongoing research evaluating the impact of the addiction consultation on addiction severity, health care costs, and utilization. She has published perspectives, reviews, and research articles in leading peer-reviewed journals, including The New England Journal of Medicine, The Journal of the American Medical Association, The Journal of General Internal Medicine, The American Journal of Medicine, Substance Abuse, and others.



    ADVISORY COUNCIL

    Mary Jo Assi, DNP, RN, NEA-BC, FNP-BC, FAAN, is the vice president of Nursing Practice and Innovation at the American Nurses Association. Areas of responsibility include Healthy Nurse, Healthy Nation, Scope and Standards of Nursing Practice, and Healthy Work Environment, with an emphasis on quality care, patient and nurse health, wellness, and safety. With over 35 years of nursing experience, Dr. Assi has worked in many different nursing roles during her career including clinical nurse, nurse educator, advanced practice nurse, and nurse executive. She graduated from Pace University Family Nurse Practitioner program in 1998 and obtained her doctorate from the George Washington University DNP program in 2014. Prior to joining the American Nurses Association, Dr. Assi worked in an administrative capacity in the roles of director of Advanced Practice Nursing, and director of Professional Practice in both a community-based and urban academic medical center. She led multiple initiatives to develop advanced practice registered nurse roles and services. She also served as an ANCC magnet commissioner for six years, and as a magnet program director (MPD) in a large academic medical center. As an MPD, Dr. Assi worked with nurses at all levels of practice through nursing’s shared governance model to develop and maintain standards of nursing excellence with respect to professional nursing practice. Dr. Assi was recently inducted as a fellow to the American Academy of Nursing.

    Dean Babcock, LCSW, LCAC, CTP PI, serves on a wide variety of boards and committees providing clinical and administrative expertise regarding issues related to addiction and mental health. Mr. Babcock is a member of the Marion County Indiana Heroin Roundtable and the Indiana Health, Safety, and Education Coalition. He serves in a leadership capacity in three major Screening, Brief Intervention, and Referral to Treatment (SBIRT) initiatives that involve implementing SBIRT and SBIRT education with the Indiana Division of Mental Health and Addiction, Indiana University, healthcare organizations, and the Indiana National Guard.

    In 2014, Mr. Babcock joined the Marion County Marijuana Task Force. He participated in development and analysis of the Marion County Health Assessment, and was instrumental in the Indiana Re-Think Tobacco Steering Committee.

    Recently, he joined the Great Lakes ATTC Indiana Local Advisory Board. He provides numerous testimonies in the Indiana legislature on the treatment of opioid dependence, and consults on Indiana law related to the operation of Indiana opiate treatment programs. He serves in an advisory capacity to law enforcement, faith-based organizations, health care systems, and professional education systems related to his clinical expertise on addiction.

    Jean Bennett, PhD, MSM, MSN, RN, has served since 2011 as the regional administrator for the Substance Abuse and Mental Health Services Administration, the HHS operating division charged with reducing the impact of substance abuse and mental illness on America’s communities. A sampling of the regional priorities Dr. Bennett has addressed in collaboration with a wide array of stakeholders in her Region III territory (PA, MD, DC, DE, VA and WV) include behavioral health workforce development, interdisciplinary addiction education, patient-centered outcomes research, suicide prevention, and public health priorities such as opioid overdose prevention. Since 2014, Dr. Bennett has convened the medical schools in Region III to address addiction education priorities on two dozen occasions, and advised or convened addiction-related or opioid task forces at the city, state, regional, and national levels.

    Dr. Bennett’s experience includes public health emergency preparedness and response (HHS Region VI, Department of Veterans Affairs VISN 21, Children’s Hospital Boston); recruiting (Navy Recruiting Command, Atlantic Fleet Career Information Team); academia (Northeastern University School of Nursing); and clinical supervision in medical, surgical, mental health, and home health (Naval Regional Medical Centers, Sentara -Norfolk, VA). Dr. Bennett's academic preparation includes a PhD in Organization and Management from Capella University, a MS in Nursing of Children from the University of Pennsylvania, a MS in Management from Troy State University, and a BS in Nursing from the University of Rhode Island. Dr. Bennett's research has been focused on the topics of prevention, addiction, hospital evacuation, and electronic communication. She retired at the senior officer rank of Captain (0-6) after 20 years of military service as a Nurse Corps officer and seven duty station assignments.

    Monica Bharel, MD, MPH, became commissioner of the Massachusetts Department of Public Health in February 2015. As commissioner, she is responsible for spearheading the state's response to the opioid crisis, as well as leading the department’s implementation of health care cost containment legislation, Chapter 224, reducing health disparities, finding public health solutions for health care reform, finding innovative solutions using data and evidence-based practices, and other health care quality improvement initiatives.

    Dr. Bharel is widely recognized for her dedication to health care for underserved and vulnerable populations, having previously served as the chief medical officer of the Boston Health Care for the Homeless Program, the largest nonprofit health care organization for homeless individuals in the country.

    Dr. Bharel has served on the faculty of Harvard Medical School, Boston University Medical School, and Harvard School of Public Health. She was previously at Massachusetts General Hospital and Boston Medical Center. She has practiced general internal medicine for 20 years in neighborhood health centers, city hospitals, the Veterans Administration, university hospitals, and nonprofit organizations.

    Dr. Bharel received her Master of Public Health degree through the Commonwealth Fund/Harvard University Fellowship in Minority Health Policy. She received her medical degree from Boston University School of Medicine, and completed a residency and chief residency in internal medicine at Boston City Hospital/Boston Medical Center.

    Patricia Bruckenthal, PhD, APRN-BC, FAAN, is an associate professor in the Stony Brook University School of Nursing and has worked a nurse practitioner in pain management for over 20 years. She received her undergraduate and graduate nursing degrees at Stony Brook and her PhD at the University of Massachusetts, Amherst. Her post doctorate traineeship was completed at the Applied Behavioral Medicine Research Institute at Stony Brook University.

    Dr. Bruckenthal has presented at numerous national and international conferences on pain management issues and is a member of several clinical and research nursing and pain societies. She is a past president of the American Society for Pain Management Nursing. She has numerous peer-reviewed publications.

    Dr. Bruckenthal’s research focuses on self-management of chronic pain, and pain assessment and management of older adults. She was a co-investigator on a multi-site clinical trial of Pain Coping Skills Training for patients with chronic osteoarthritis pain. This trial demonstrated the effectiveness of this treatment delivery by nurse practitioners—a major advance for improving access to this option for pain management. Currently, she is engaged in teaching health care practitioners how to incorporate self-management skills into routine care visits.

    Kathryn Cates-Wessel has over 30 years of experience working in administration, medical education, grants management, and policy, investing her skills and expertise in the field of substance use disorders since her earliest working endeavors.

    Throughout her career, she secured a number of successively important positions in the field. She initially began developing training materials for an Employee Assistance Program to ensure supervisors could identify substance use disorders and refer their employees to treatment resources. Thereafter, she became the director of administration for a residential treatment center for adolescents with substance use disorders and co-occurring mental disorders, where key responsibilities included overseeing human resources, facilities, JCAHO accreditation, and community relations. Working alongside Dr. David Lewis, a pioneer in the field of addictions, Mrs. Cates-Wessel worked in the Center for Alcohol and Addiction Studies at Brown University for over 19 years as associate director of the center.

    Mrs. Cates-Wessel expanded her work from administration, medical education, program development and grants management to become principal investigator on private grants as well as director of Physicians and Lawyers for National Drug Policy—a think-tank consisting of nationally recognized public health leaders, attorneys, and law experts who advocated for the prevention and treatment of those afflicted by substance use disorders interfacing with the justice system. Among such leaders were former surgeon generals of the US, assistant secretaries of Health and Human Services, deans of major medical schools, and leaders in law, including the president of National Judicial College and Federal Judicial College.

    Mrs. Cates-Wessel currently serves as the executive director of the American Academy of Addiction Psychiatry, where she is principal investigator and project director for key SAMHSA-funded initiatives including Provider’s Clinical Support System for Medication Assisted Treatment and Providers Clinical Support System for Opioid Therapies, as well as other grants focused on training and education for health professionals. These programs focus on the need for primary care and addiction-specialty professional organizations and key stakeholders to come together to provide evidence-based training and educational resources on the prevention, identification, and continuum of care for substance use disorders.

    Rick Garcia, PhD, RN, CCM, has over 20 years of active nursing practice across a multitude of administrative and clinical settings. Dr. Garcia maintains an active practice in New York City at an ambulatory surgical hospital. His clinical specialty areas of practice include neonatal intensive care, post-anesthesia care unit (recovery room), neurosurgery, urology, otorhinolaryngology, case management, and ophthalmology. His experience includes serving as chair of the Education Committee and registered nurse member of the District of Columbia Board of Nursing. He has served as the executive director of the Florida Board of Nursing, focusing on regulation, licensure, and discipline of nurses and nursing programs. Most recently, he served on the New York State Board of Nursing as chair of the Practice Committee and a registered professional nurse member. Currently, Dr. Garcia is engaged in education policy work in the capacity of director of Nursing Education at the American Association of Colleges of Nursing, which serves as the voice of academic nursing and represents over 790 member schools.

    Marie Michele Léger, MPH, PA-C, a PA for 33 years, is director of clinical education for the American Academy of Physician Assistants (AAPA). She obtained a Bachelor of Science, Physician Assistant Program, George Washington University (GWU), Washington, D.C., in 1983, and completed her Master in Public Health, focusing on international health with a concentration in health promotion/disease prevention, from GWU in 1996.

    She monitors and advises AAPA’s leadership on issues in clinical medicine and public health, coordinates activities that relate to continuous professional development, and translates best available evidence which leads to PA practice improvement. Ms. Léger is the AAPA’s liaison to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). She has published extensively including writing editorials on raising the awareness of emergency preparedness and raising the rate of adult immunization. Ms. Léger has given presentations in the United States and internationally addressing the PA profession, disparity in health care, immunization, and other infectious disease topics. Ms. Léger retains a faculty appointment at the George Washington University School of Medicine and Health Sciences and at the Shenandoah Physician Assistant Program.

    Anne Norman, DNP, APRN, FNP-C, FAANP, is a family nurse practitioner (FNP) and the vice president of education and accreditation at the American Association of Nurse Practitioners (AANP). She received her Master of Science in Nursing at the University of Alabama at Huntsville in 1994 and her Doctor of Nursing Practice at the University of Alabama at Birmingham in 2010. Dr. Norman has practiced in primary care and held leadership positions in various settings including a multiple disciplinary medical school health center, rural health, college health, retail health, and workplace/occupational health. At AANP, she serves as the primary organizational resource on continuing education (CE) and education-related standards, recommendations, and requirements. Her responsibilities include directing the grant, education, and accreditation activities of the association by overseeing and guiding the planning, development, and implementation of educational activities and programs to meet strategic goals.

    John Renner, Jr., MD, is professor of psychiatry, Boston University School of Medicine, and associate chief of psychiatry for the Veterans Association (VA) Boston Healthcare System. He graduated from Yale University and Case University School of Medicine.

    Since 1979, Dr. Renner has been working at the Boston VA where he currently directs their outpatient addiction treatment program. In addition, he is associate director of the Boston University Medical Center General Psychiatry Residency Program and director of their Addiction Psychiatry Residency.

    Dr. Renner has written and lectured extensively on the treatment of alcoholism and drug addiction. He is president of the American Academy of Addiction Psychiatry, and vice chair of the American Psychiatric Association Council on Addiction Psychiatry. In 2010, Dr. Renner co-edited the Handbook of Office-Based Buprenorphine Treatment for the American Psychiatric Press, Inc. He is a member of the Data Safety Monitoring Board for the Clinical Trials Network of the National Institute on Drug Abuse, a member of the Clinical Advisory Committee of the Physician Health Service of the Massachusetts Medical Society, a consultant to the Department of Psychiatry, Massachusetts General Hospital, and a member of the faculty of the Harvard Medical School Division on Addictions. He is also former medical director of the SAMHSA-funded Physicians Clinical Support System-Buprenorphine.

    Alexander F. Ross, ScD, is senior advisor on behavioral health in the Office of Planning, Analysis and Evaluation at the Health Resources and Services Administration (HRSA), US Department of Health and Human Services. In addition to focusing on behavioral health workforce and education programs, Dr. Ross supports HRSA bureaus and offices fostering the integration of behavioral health and primary care. His work has included an emphasis on financing issues regarding behavioral health/primary care services and assuring that an appropriately trained health care workforce is available to meet the nation’s needs. Dr. Ross is the HRSA project officer on the SAMHSA/HRSA Center for Integrated Health Solutions. He has a Doctor of Science Degree in Health Policy from The Johns Hopkins University School of Hygiene and Public Health.

    Rich Saitz, MD, MPH, FACP (Fellow, American College of Physicians), DFASAM (Distinguished Fellow, American Society of Addiction Medicine), is a general internist (diplomate of the American Board of Internal Medicine, DABIM) and primary care physician, an addiction medicine specialist (diplomate of the American Board of Addiction Medicine, DABAM), chair and professor of Community Health Sciences at Boston University (BU) School of Public Health, and professor of medicine at BU School of Medicine. He chaired the Treatment and Services Review Committee for the National Institute on Alcohol Abuse and Alcoholism, is editor of Evidence-Based Medicine and senior editor of Journal of Addiction Medicine, section editor and sole author of key chapters in UpToDate on unhealthy substance use, an editor of the ASAM textbook Principles of Addiction Medicine, editor emeritus of Addiction Science and Clinical Practice, and author of over 200 peer-reviewed publications.

    Dr. Saitz was director of Boston Medical Center’s Clinical Addiction Research and Education (CARE) Unit for over a decade, has been chairman of an Institutional Review Board, associate director of clinical research for BU, president of the Association for Medical Education and Research in Substance Abuse (AMERSA), steering committee member of the Motivational Interviewing Network of Trainers (MINT), and is coordinating committee member of International Network for Brief Intervention for Alcohol and other drug problems (INEBRIA).He is on the International Society of Addiction Journal Editors (ISAJE) Board now as vice president. His primary areas of expertise, supported by NIH, RWJF, and SAMHSA, are screening and brief intervention, integrating substance-related and general health care, improving the quality of care for people with unhealthy substance use—particularly in general health settings—and basing care on science. He validated single-item screening questions recommended by NIDA and NIAAA.

    Dr. Saitz’s awards include: Alpha Omega Alpha Honor Society; Boston Jaycees Ten Outstanding Young Leaders Award; Best Doctors in America®; AMERSA’s W. Anderson Spickard, Jr. Excellence in Mentorship Award; the R. Brinkley Smithers Distinguished Scientist Award (ASAM); Research Society on Alcoholism Distinguished Researcher Award.

    Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP, FIAAN, is clinical associate professor at the University of Michigan School of Nursing, and the Department of Psychiatry. He is board certified in both psychiatric and addictions nursing. His professional background has included clinical care, research, administration, and education. Dr. Strobbe was the first clinical director for the University of Michigan Addictions Treatment Services (UMATS). He has authored peer-reviewed articles, position statements, book chapters, and other works related to substance use and addictions nursing. He has been an invited speaker both nationally and internationally.

    In 2015, Professor Strobbe received the 25th Annual Golden Apple Award, the only student-nominated and student-selected teaching award at the University of Michigan. He is the current president of the International Nurses Society on Addictions (2016-2018), and co-chair for the Washtenaw Health Initiative Opioid Project. In October 2016, Dr. Strobbe was inducted as a fellow of the International Academy of Addictions Nursing.



    THE OPIOID USE DISORDER EDUCATION PROGRAM

    Three courses make up the Opioid Use Disorder Education Program (OUDEP). Although they are being released one at a time, they may be taken in any order. The courses are as follows:

    Understanding Addiction focuses on the fundamentals regarding the nature of addiction including the epidemiology of opioid use disorder, the chronic nature of OUD, the differences between dependence and use disorders, and the neurobiology behind addiction. It also looks at the changing perceptions and current stigmas surrounding opioid use disorders.

    Identification, Counseling, and Treatment of OUD focuses on best practices and treatment of OUD with different medications in addition to psychosocial approaches. It also addresses co-occurring psychiatric disorders as well as preventing and treating overdose.

    Collaborative Care Approaches for the Management of OUD focuses on strategies that include provider roles and regulatory requirements, patient evaluation and education, and transitioning between medications. It also addresses potential misuse, relapse, and safer use, as well as caring for pregnant women and other special populations with OUD.

    FREQUENTLY ASKED QUESTIONS

    How long will this course take?

    This course should take approximately 8 hours to complete. You do not need to complete it all at once. You may come back as often as you like.

    How long will this course be available?

    This self-paced course will close enrollments one year after its start date.

    What web browser should I use?

    The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 9 and above. See our list of supported browsers for the most up-to-date information.

    What if I want to learn more about this topic?

    HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.

    Enroll